Allergan plc have announced that it has acquired Anterios, Inc., a clinical stage biopharmaceutical company developing a next generation delivery system and botulinum toxin-based prescription products. Under the terms of the

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In